AngioDynamics, Inc.  

(Public, NASDAQ:ANGO)   Watch this stock  
Find more results for ANGO
15.85
+0.03 (0.16%)
Real-time:   3:36PM EDT
NASDAQ real-time data - Disclaimer
Currency in USD
Range 15.76 - 15.99
52 week 11.73 - 18.18
Open 15.80
Vol / Avg. 106,528.00/325,107.00
Mkt cap 588.87M
P/E     -
Div/yield     -
EPS -0.70
Shares 36.79M
Beta 1.07
Inst. own 98%
Jul 11, 2017
Q4 2017 AngioDynamics Inc Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
May 22, 2017
AngioDynamics Inc at UBS Global Healthcare Conference - Webcast
May 4, 2017
AngioDynamics Inc at Deutsche Bank Health Care Conference - Webcast
Apr 6, 2017
AngioDynamics Inc Investor Day - Webcast
Mar 30, 2017
Q3 2017 AngioDynamics Inc Earnings Release
Mar 30, 2017
Q3 2017 AngioDynamics Inc Earnings Call - Webcast
Mar 16, 2017
AngioDynamics Inc at Barclays Global Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q1 (Feb '17) 2016
Net profit margin 3.37% -12.32%
Operating margin 6.00% 0.29%
EBITD margin - 12.06%
Return on average assets 1.63% -5.81%
Return on average equity 2.19% -8.28%
Employees 1,300 -
CDP Score - -

Address

14 Plaza Dr
LATHAM, NY 12110-2166
United States - Map
+1-518-7981215 (Phone)
+1-518-7951401 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

AngioDynamics, Inc. designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. The Company's devices are used in minimally invasive, image-guided procedures. The Company offers products within three product groupings: Peripheral Vascular, Vascular Access and Oncology/Surgery. The Company's Peripheral Vascular products include Fluid Management, Venous, Thrombus Management, as well as other core products. The Company's BioFlo products incorporate Endexo Technology into the manufacturing and design of its Vascular Access products. Its Oncology/Surgery product offerings include its Microwave Ablation products, Radiofrequency Ablation (RFA) and its NanoKnife product lines.

Officers and directors

Howard W. Donnelly Independent Chairman of the Board
Age: 54
Bio & Compensation  - Reuters
James C. Clemmer President, Chief Executive Officer, Director
Age: 52
Bio & Compensation  - Reuters
Michael Greiner Chief Financial Officer, Executive Vice President
Age: 43
Bio & Compensation  - Reuters
Gary Barrett Senior Vice President,Quality and Regulatory Affairs
Age: 47
Bio & Compensation  - Reuters
Ben Davis Senior Vice President, Business Development
Age: 51
Bio & Compensation  - Reuters
Barbara Kucharczyk Senior Vice President-Global Operations
Age: 42
Bio & Compensation  - Reuters
Stephen A. Trowbridge Senior Vice President, General Counsel
Age: 41
Bio & Compensation  - Reuters
Eileen O'Shea Auen Director
Age: 53
Bio & Compensation  - Reuters
Jan Stern Reed Director
Age: 57
Bio & Compensation  - Reuters
David F. Burgstahler Independent Director
Age: 48
Bio & Compensation  - Reuters